Investigational PD-L1–targeted immunotherapy safe for patients with triple-negative breast cancer

PARP inhibitor combo shows early promise for patients with and without BRCA mutations

Long-term, regular aspirin use modestly decreased cancer risk

New immunotherapy yields long-lasting responses in some patients with advanced melanoma

Extended overnight fasting may lead to reduced breast cancer risk

New data shows that generic drivers are found in benign conditions

How will genomics be applied to patient therapy in future?

Prevention of gynaecological cancers: in memory of Mario Sideri

Inside cancer - public lecture

US breast cancer cases expected to increase by as much as 50 percent by 2030

How to decide the treatment of CLL in 2015

ecancermedicalscience editor's choice for December 2014